How much profit has Spirox made this year?
Spirox has made -190.15 M TWD this year.
Spirox Net Income 2024
Spirox Net Income
-190.15 M TWD
Ticker
3055.TW
ISIN
TW0003055000
In 2024, Spirox's profit amounted to -190.15 M TWD, a 239.05% increase from the -56.09 M TWD profit recorded in the previous year.
The Spirox Net Income history
| YEAR | NET INCOME (undefined TWD) |
|---|---|
| 2025e | -99.66 |
| 2024e | -190.15 |
| 2023 | -56.09 |
| 2022 | 240.16 |
| 2021 | -357.47 |
| 2020 | -45.01 |
| 2019 | 10.17 |
| 2018 | 86.17 |
| 2017 | 38.69 |
| 2016 | 138.54 |
| 2015 | 602.29 |
| 2014 | 287.26 |
| 2013 | -503.4 |
| 2012 | 63.6 |
| 2011 | 99.5 |
| 2010 | 359.9 |
| 2009 | 203 |
| 2008 | 208.2 |
| 2007 | 780.8 |
| 2006 | 568.6 |
| 2005 | 634 |
| 2004 | 765.2 |
Spirox Revenue, EBIT, Net Income TW0003055000 ·
3 years
5 years
10 years
25 Years
Max
Revenue
EBIT
Net Income
Details
Revenue, EBIT and Profit
ⓘUnderstanding Revenue, EBIT, and Income
Gain insights into Spirox, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Spirox from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Spirox’s net earnings, an ultimate measure of its financial health and profitability.
Yearly Analysis and Comparisons
Observe the yearly bars to understand the annual performance and growth of Spirox. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.
Utilizing Expectations for Investment
The expected values for the forthcoming years offer investors a glimpse into Spirox’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.
Investment Insights
Leveraging the comparison between Revenue and EBIT helps in assessing Spirox’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Spirox’s growth potential.
Spirox Revenue, EBIT and net profit per share
| Date | Spirox Revenue | Spirox EBIT | Spirox Net Income |
|---|---|---|---|
| 2025e | 1.3 B undefined | -121.38 M undefined | -99.66 M undefined |
| 2024e | 1.23 B undefined | -117.3 M undefined | -190.15 M undefined |
| 2023 | 1.34 B undefined | -189.82 M undefined | -56.09 M undefined |
| 2022 | 1.91 B undefined | -418.29 M undefined | 240.16 M undefined |
| 2021 | 2.65 B undefined | -356.63 M undefined | -357.47 M undefined |
| 2020 | 2.02 B undefined | -178.18 M undefined | -45.01 M undefined |
| 2019 | 2.91 B undefined | -46.53 M undefined | 10.17 M undefined |
| 2018 | 3.15 B undefined | 67.98 M undefined | 86.17 M undefined |
| 2017 | 2.65 B undefined | 52.74 M undefined | 38.69 M undefined |
| 2016 | 3.51 B undefined | 170.81 M undefined | 138.54 M undefined |
| 2015 | 2.94 B undefined | 81.53 M undefined | 602.29 M undefined |
| 2014 | 3.44 B undefined | 292.8 M undefined | 287.26 M undefined |
| 2013 | 2.79 B undefined | -73.4 M undefined | -503.4 M undefined |
| 2012 | 3.31 B undefined | 54.7 M undefined | 63.6 M undefined |
| 2011 | 3.4 B undefined | 117.2 M undefined | 99.5 M undefined |
| 2010 | 4.8 B undefined | 314 M undefined | 359.9 M undefined |
| 2009 | 2.75 B undefined | 106.7 M undefined | 203 M undefined |
| 2008 | 3.97 B undefined | 76 M undefined | 208.2 M undefined |
| 2007 | 7.14 B undefined | 555.7 M undefined | 780.8 M undefined |
| 2006 | 7.03 B undefined | 555.7 M undefined | 568.6 M undefined |
| 2005 | 7.78 B undefined | 698.1 M undefined | 634 M undefined |
| 2004 | 9.34 B undefined | 1.07 B undefined | 765.2 M undefined |
| Revenue | EBIT | Net Income | |
|---|---|---|---|
| 2004 | 9.34 B TWD | 1.07 B TWD | 765.2 M TWD |
| 2005 | 7.78 B TWD | 698.1 M TWD | 634 M TWD |
| 2006 | 7.03 B TWD | 555.7 M TWD | 568.6 M TWD |
| 2007 | 7.14 B TWD | 555.7 M TWD | 780.8 M TWD |
| 2008 | 3.97 B TWD | 76 M TWD | 208.2 M TWD |
| 2009 | 2.75 B TWD | 106.7 M TWD | 203 M TWD |
| 2010 | 4.8 B TWD | 314 M TWD | 359.9 M TWD |
| 2011 | 3.4 B TWD | 117.2 M TWD | 99.5 M TWD |
| 2012 | 3.31 B TWD | 54.7 M TWD | 63.6 M TWD |
| 2013 | 2.79 B TWD | -73.4 M TWD | -503.4 M TWD |
| 2014 | 3.44 B TWD | 292.8 M TWD | 287.26 M TWD |
| 2015 | 2.94 B TWD | 81.53 M TWD | 602.29 M TWD |
| 2016 | 3.51 B TWD | 170.81 M TWD | 138.54 M TWD |
| 2017 | 2.65 B TWD | 52.74 M TWD | 38.69 M TWD |
| 2018 | 3.15 B TWD | 67.98 M TWD | 86.17 M TWD |
| 2019 | 2.91 B TWD | -46.53 M TWD | 10.17 M TWD |
| 2020 | 2.02 B TWD | -178.18 M TWD | -45.01 M TWD |
| 2021 | 2.65 B TWD | -356.63 M TWD | -357.47 M TWD |
| 2022 | 1.91 B TWD | -418.29 M TWD | 240.16 M TWD |
| 2023 | 1.34 B TWD | -189.82 M TWD | -56.09 M TWD |
| 2024e | 1.23 B TWD | -117.3 M TWD | -190.15 M TWD |
| 2025e | 1.3 B TWD | -121.38 M TWD | -99.66 M TWD |
Spirox stock margins TW0003055000 ·
The Spirox margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Spirox. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Spirox.
3 years
5 years
10 years
25 Years
Max
Gross margin
EBIT margin
Profit margin
Details
Margin
ⓘUnderstanding Gross Margin
The gross margin, expressed as a percentage, delineates the gross profit made from the Spirox's sales revenue. A higher gross margin percentage indicates that the Spirox retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.
EBIT Margin Analysis
EBIT margin represents the Spirox's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.
Revenue Margin Insights
The revenue margin demonstrates the Spirox's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Spirox's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.
Interpreting Expectations
The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Spirox. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.
Comparative Analysis
Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Spirox's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.
Spirox Margin History
| Spirox Gross margin | Spirox Profit margin | Spirox EBIT margin | Spirox Profit margin |
|---|---|---|---|
| 2025e | 17.76 % | -9.37 % | -7.7 % |
| 2024e | 17.76 % | -9.53 % | -15.45 % |
| 2023 | 17.76 % | -14.14 % | -4.18 % |
| 2022 | 8.97 % | -21.85 % | 12.54 % |
| 2021 | 11.51 % | -13.48 % | -13.51 % |
| 2020 | 18.48 % | -8.84 % | -2.23 % |
| 2019 | 18.77 % | -1.6 % | 0.35 % |
| 2018 | 22.36 % | 2.16 % | 2.73 % |
| 2017 | 21.86 % | 1.99 % | 1.46 % |
| 2016 | 21.23 % | 4.86 % | 3.94 % |
| 2015 | 22.02 % | 2.78 % | 20.51 % |
| 2014 | 24.34 % | 8.5 % | 8.34 % |
| 2013 | 17.49 % | -2.63 % | -18.07 % |
| 2012 | 21.28 % | 1.65 % | 1.92 % |
| 2011 | 21.05 % | 3.45 % | 2.93 % |
| 2010 | 20.03 % | 6.54 % | 7.5 % |
| 2009 | 23.38 % | 3.88 % | 7.37 % |
| 2008 | 20.45 % | 1.92 % | 5.25 % |
| 2007 | 18.02 % | 7.78 % | 10.93 % |
| 2006 | 19.83 % | 7.91 % | 8.09 % |
| 2005 | 20.32 % | 8.97 % | 8.14 % |
| 2004 | 20.9 % | 11.47 % | 8.19 % |
| Gross margin | EBIT margin | Profit margin | |
|---|---|---|---|
| 2004 | 20.9 % | 11.47 % | 8.19 % |
| 2005 | 20.32 % | 8.97 % | 8.14 % |
| 2006 | 19.83 % | 7.91 % | 8.09 % |
| 2007 | 18.02 % | 7.78 % | 10.93 % |
| 2008 | 20.45 % | 1.92 % | 5.25 % |
| 2009 | 23.38 % | 3.88 % | 7.37 % |
| 2010 | 20.03 % | 6.54 % | 7.5 % |
| 2011 | 21.05 % | 3.45 % | 2.93 % |
| 2012 | 21.28 % | 1.65 % | 1.92 % |
| 2013 | 17.49 % | -2.63 % | -18.07 % |
| 2014 | 24.34 % | 8.5 % | 8.34 % |
| 2015 | 22.02 % | 2.78 % | 20.51 % |
| 2016 | 21.23 % | 4.86 % | 3.94 % |
| 2017 | 21.86 % | 1.99 % | 1.46 % |
| 2018 | 22.36 % | 2.16 % | 2.73 % |
| 2019 | 18.77 % | -1.6 % | 0.35 % |
| 2020 | 18.48 % | -8.84 % | -2.23 % |
| 2021 | 11.51 % | -13.48 % | -13.51 % |
| 2022 | 8.97 % | -21.85 % | 12.54 % |
| 2023 | 17.76 % | -14.14 % | -4.18 % |
| 2024e | 17.76 % | -9.53 % | -15.45 % |
| 2025e | 17.76 % | -9.37 % | -7.7 % |
Spirox Aktienanalyse
What does Spirox do?
The Spirox Corporation is a company that was founded in 2007 and is headquartered in Menlo Park, California. The company operates in the medical technology industry and specializes in the development of products for nasal breathing. The mission of Spirox is to help people who have difficulty breathing through their nose. The company has recognized that many people have difficulty breathing through their nose due to congestion or other issues. Breathing through the mouth, however, can lead to a range of health problems such as dry mouth, sleep apnea, and respiratory infections. Therefore, Spirox has set out to develop innovative solutions to facilitate nasal breathing. Spirox's products include both implantable and non-implantable solutions. The company has a small but effective product portfolio consisting of two products: the Latera Nasal Stent and the AeroForm Nasal Stent. The Latera Nasal Stent is used to permanently open the nasal passages and facilitate breathing. The placement of the stent is a minimally invasive procedure that is typically performed on an outpatient basis. The Latera Nasal Stent is inserted and secured in the nasal wings to allow for better airflow through the nostrils. The stent is made of polydioxanone (PDO), a biocompatible polymer fiber that is absorbed by the body. Spirox's second product, the AeroForm Nasal Stent, is a non-implantable nasal stent used for temporary relief of nasal breathing. The AeroForm is a soft stent made of a flexible polymer material. It is inserted into the nasal passages and forms a gentle expansion to facilitate nasal breathing. As a company, Spirox focuses on collaboration with specialists and clinics to ensure that their products have high success rates. The company has established a partnership with the American Academy of Otolaryngology - Head and Neck Surgery (AAO-HNS) to advance scientific research and development in the nasal breathing industry. Spirox is led by experienced executives from the medical technology industry. The CEO, Duke Rohlen, has over 20 years of experience in leading medical technology companies such as Inspire Medical Systems and CV Ingenuity. The board team also includes Elektra Papadopoulos as Chair of the Board, who has worked at Hologic and Boston Scientific, among others. Although Spirox is a relatively small company, it has already received several awards. In 2017, the company was awarded the Red Herring Top 100 North America Award, which recognizes companies that are leading in the innovation industry. Overall, Spirox is an emerging company in the medical technology industry that offers innovative solutions to facilitate nasal breathing. Through collaboration with doctors and clinics and a focus on scientific research, the company aims to improve the success and effectiveness of its products. Spirox ist eines der beliebtesten Unternehmen auf Eulerpool.com.Net Income Details
Understanding Spirox's Profit Margins
The profit margins of Spirox represent the net income earned after deducting all operational expenses, costs, and taxes from the revenue. This figure is a clear indicator of Spirox's financial health, operational efficiency, and profitability. Higher profit margins signify better cost management and income generation capabilities.
Year-to-Year Comparison
Evaluating Spirox's profit on a yearly basis can offer significant insights into its financial growth, stability, and trends. A consistent increase in profit suggests improved operational efficiency, cost management, or increased revenue, while a decrease may indicate rising costs, declining sales, or operational challenges.
Impact on Investments
Spirox's profit figures are critical for investors who are aiming to understand the company's financial standing and future growth prospects. Increased profits often lead to higher stock valuations, boosting investor confidence and attracting more investments.
Interpreting Profit Fluctuations
When Spirox’s profit increases, it often indicates enhanced operational efficiency or increased sales. In contrast, a decline in profit can signal operational inefficiencies, increased costs, or competitive pressures, necessitating strategic interventions to boost profitability.
Frequently Asked Questions about Spirox stock
How has the profit developed compared to last year?
The profit has increased by 239.05% compared to last year increased
What impact do the earnings have on the shareholders?
An increase in earnings is usually seen as a positive indicator for shareholders as it means that the company is generating profits.
How does Spirox publish its earnings?
Spirox publishes its earnings in the form of quarterly or annual reports.
Which financial indicators are included in the quarterly or annual reports?
The quarterly or annual reports contain information about sales and profit, cash flow, balance sheet, and other fundamentals.
Why is it important for investors to know the earnings of Spirox?
The profits of Spirox are an important indicator of the financial health of the company and can help investors decide whether they want to invest in the company or not.
How can one learn more about the earnings of Spirox?
You can learn more about the earnings of Spirox by reviewing the quarterly or annual reports or following the company presentations.
How much dividend does Spirox pay?
Over the past 12 months, Spirox paid a dividend of 1 TWD . This corresponds to a dividend yield of about 1.34 %. For the coming 12 months, Spirox is expected to pay a dividend of 0.87 TWD.
What is the dividend yield of Spirox?
The current dividend yield of Spirox is 1.34 %.
When does Spirox pay dividends?
Spirox pays a quarterly dividend. This is distributed in the months of October, August, August, August.
How secure is the dividend of Spirox?
Spirox paid dividends every year for the past 0 years.
What is the dividend of Spirox?
For the upcoming 12 months, dividends amounting to 0.87 TWD are expected. This corresponds to a dividend yield of 1.16 %.
In which sector is Spirox located?
Spirox is assigned to the 'Information technology' sector.
Wann musste ich die Aktien von Spirox kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Spirox from 8/6/2024 amounting to 1.011 TWD, you needed to have the stock in your portfolio before the ex-date on 7/5/2024.
When did Spirox pay the last dividend?
The last dividend was paid out on 8/6/2024.
What was the dividend of Spirox in the year 2023?
In the year 2023, Spirox distributed 0.2 TWD as dividends.
In which currency does Spirox pay out the dividend?
The dividends of Spirox are distributed in TWD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Spirox
Our stock analysis for Spirox Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Spirox Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.